Burden of serious XXXX in Belgium.

@entity1 @entity82 @entity57 @entity6923 @entity3217 @entity55 @entity1330 @entity565 @entity645 @entity281 @entity364 @entity19141 @entity3 @entity7678 @entity791
We aimed to estimate the total number of serious @entity364 occurring yearly in Belgium. The number of @entity281 was retrieved from the National Reference Center for @entity3217 . Populations at risk and @entity364 frequencies in these populations were used to estimate incidence or prevalence of other @entity364 . The Belgian population consists of 11.10 million @entity1 . @entity1330 is rare. In all, 15 of the 1227 newly diagnosed @entity645 / @entity791 cases presented with @entity19141 jirovecii @entity55 . This accounts for   14% of total @entity7678 cases (n  =  120). The incidence of candidaemia is estimated as 5/100  000 resulting in 555 cases and 213 deaths. A total number of 675 @entity3 cases and >= 169 deaths attributed to this infection were calculated. Chronic @entity57 is estimated to be prevalent in 662 cases. Allergic @entity57 cases were estimated to be 23  119 applying a 2.5% and 15% rate in adult @entity565 and cystic @entity82 @entity1 respectively. Severe @entity565 with fungal sensitisation cases was estimated to be 30  402. There were 174  760 @entity1 with recurrent @entity6923 assuming a 6% rate in @entity1 aged between 15 and 50. Approximately 233  000 @entity1 of the Belgian population (2.1%) are estimated to suffer from a @entity364 on a yearly basis.
